연구성과로 돌아가기

2020 연구자 정보 (65 / 997)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Park, Hyo Seon
(Park, HS) ⓘ 		Yonsei Univ, Dept Architecture & Architectural Engn, Seoul 03722, South Korea
Yonsei Univ, Dept Architectural Engn, Seoul 120749, South Korea
Yonsei Univ, Dept Architecture & Architectural Engn, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.0] An integrated psychological score for occupants based on their perception and emotional response according to the windows' outdoor view size
[JCR상위 35.7] Multi-objective sustainable design model for integrating CO2 emissions and costs for slabs in office buildings
[JCR상위 4.0] An empirical analysis of environmental pollutants on building construction sites for determining the real-time monitoring indices
[JCR상위 4.0] Quantitative health impact assessment of construction noise exposure on the nearby region for noise barrier optimization ⓘ 		SCIE ⓘ 4.0 CONSTRUCTION & BUILDING TECHNOLOGY;ENGINEERING, CIVIL;ENGINEERING, ENVIRONMENTAL
ENGINEERING, CIVIL;ENGINEERING, MECHANICAL ⓘ 		hong7@yonsei.ac.kr;
hspark@yonsei.ac.kr;
juwonae@yonsei.ac.kr;hyuna_kang@yonsei.ac.kr;saber21@yonsei.ac.kr;seulki0507@yonsei.ac.kr;hong7@yonsei.ac.kr;hspark@yonsei.ac.kr;dolee@knu.ac.kr;
saber21@yonsei.ac.kr;hyuna_kang@yonsei.ac.kr;jinwoo818@yonsei.ac.kr;hong7@yonsei.ac.kr;hspark@yonsei.ac.kr;dolee@knu.ac.kr; ⓘ
Shrestha, Aarajana
(Shrestha, A) ⓘ 		Daegu Gyeongbuk Med Innovat Fdn, New Drug Dev Ctr, Daegu 41061, South Korea
Yeungnam Univ, Coll Pharm, Gyongsan 38541, South Korea ⓘ
ⓘ 		0000-0002-3047-6574
Shrestha, Aarajana ⓘ 		[JCR상위 4.0] Targeting Peroxisome Proliferator-Activated Receptor Delta (PPARδ): A Medicinal Chemistry Perspective ⓘ SCIE ⓘ 4.0 CHEMISTRY, MEDICINAL ⓘ sjcho@dgmif.re.kr;jwchin@dgmif.re.kr; ⓘ
Song, Huijin
(Song, HJ) ⓘ 		제1저자 Kyungpook Natl Univ, Inst Biomed Engn Res, Daegu 41944, South Korea ⓘ
ⓘ
ⓘ 		Moderate Exercise Improves Brain Efficiency for Executive Functions in Young Adults
[JCR상위 4.0] Gadolinium-Based Neuroprognostic Magnetic Resonance Imaging Agents Suppress COX-2 for Prevention of Reperfusion Injury after Stroke ⓘ 		SCIE ⓘ 4.0 CHEMISTRY, MEDICINAL ⓘ ychang@knu.ac.kr; ⓘ
Song, Jin Sook
(Song, JS) ⓘ 		Korea Res Inst Chem Technol, Bio & Drug Discovery Div, Daejeon, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.0] Design, Synthesis, and Biological Evaluation of New Peripheral 5HT2A Antagonists for Nonalcoholic Fatty Liver Disease ⓘ SCIE ⓘ 4.0 CHEMISTRY, MEDICINAL ⓘ hailkim@kaist.edu;jhahn@gist.ac.kr; ⓘ
Song, Minsoo
(Song, M) ⓘ 		제1저자 교신저자 Daegu Gyeongbuk Med Innovat Fdn DGMIF, New Drug Dev Ctr NDDC, Daegu 41061, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.0] DNA-Encoded Library Screening as Core Platform Technology in Drug Discovery: Its Synthetic Method Development and Applications in DEL Synthesis ⓘ SCIE ⓘ 4.0 CHEMISTRY, MEDICINAL ⓘ msong@dgmif.re.kr;giltae@knu.ac.kr; ⓘ
Stephenson, Tesia N.
(Stephenson, TN) ⓘ 		Duke Univ, Dept Chem, Durham, NC 27708 USA ⓘ
ⓘ 		0000-0002-6869-9845
Stephenson, Tesia ⓘ 		[JCR상위 4.0] Evaluation of Manassantin A Tetrahydrofuran Core Region Analogues and Cooperative Therapeutic Effects with EGFR Inhibition ⓘ SCIE ⓘ 4.0 CHEMISTRY, MEDICINAL ⓘ lym@knu.ac.kr;jiyong.hong@duke.edu; ⓘ
Sung, Seulki
(Sung, S) ⓘ 		Yonsei Univ, Dept Architecture & Architectural Engn, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.0] An empirical analysis of environmental pollutants on building construction sites for determining the real-time monitoring indices ⓘ SCIE ⓘ 4.0 CONSTRUCTION & BUILDING TECHNOLOGY;ENGINEERING, CIVIL;ENGINEERING, ENVIRONMENTAL ⓘ juwonae@yonsei.ac.kr;hyuna_kang@yonsei.ac.kr;saber21@yonsei.ac.kr;seulki0507@yonsei.ac.kr;hong7@yonsei.ac.kr;hspark@yonsei.ac.kr;dolee@knu.ac.kr; ⓘ
Yeom, Seungkeun
(Yeom, S) ⓘ 		제1저자 Yonsei Univ, Dept Architecture & Architectural Engn, Seoul 03722, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.0] An integrated psychological score for occupants based on their perception and emotional response according to the windows' outdoor view size ⓘ SCIE ⓘ 4.0 CONSTRUCTION & BUILDING TECHNOLOGY;ENGINEERING, CIVIL;ENGINEERING, ENVIRONMENTAL ⓘ hong7@yonsei.ac.kr; ⓘ
Yoo, Eun Kyung
(Yoo, EK) ⓘ 		Kyungpook Natl Univ Hosp, Leading Edge Res Ctr Drug Discovery & Dev Diabet, Daegu 41010, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.0] Design, Synthesis, and Biological Evaluation of New Peripheral 5HT2A Antagonists for Nonalcoholic Fatty Liver Disease ⓘ SCIE ⓘ 4.0 CHEMISTRY, MEDICINAL ⓘ hailkim@kaist.edu;jhahn@gist.ac.kr; ⓘ
Yoon, Jihyeon
(Yoon, J) ⓘ 		Gwangju Inst Sci & Technol, Dept Chem, Gwangju 61005, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.0] Design, Synthesis, and Biological Evaluation of New Peripheral 5HT2A Antagonists for Nonalcoholic Fatty Liver Disease ⓘ SCIE ⓘ 4.0 CHEMISTRY, MEDICINAL ⓘ hailkim@kaist.edu;jhahn@gist.ac.kr; ⓘ
Chang, Dae-il
(Chang, DI) ⓘ 		Kyung Hee Univ Hosp, Dept Neurol, Seoul, South Korea ⓘ AAJ-5290-2020
Chang, Dae-il ⓘ
ⓘ 		[JCR상위 4.1] Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE-TPA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study ⓘ SCIE ⓘ 4.1 CLINICAL NEUROLOGY;NEUROSCIENCES ⓘ jongskim@amc.seoul.kr; ⓘ
Ju, Chung
(Ju, C) ⓘ 		Res Headquarters, Shin Poong Pharmaceut, Ansan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.1] Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE-TPA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study ⓘ SCIE ⓘ 4.1 CLINICAL NEUROLOGY;NEUROSCIENCES ⓘ jongskim@amc.seoul.kr; ⓘ
Kim, Byung Su
(Kim, BS) ⓘ 		Res Headquarters, Shin Poong Pharmaceut, Ansan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.1] Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE-TPA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study ⓘ SCIE ⓘ 4.1 CLINICAL NEUROLOGY;NEUROSCIENCES ⓘ jongskim@amc.seoul.kr; ⓘ
Kim, Eung-Gyu
(Kim, EG) ⓘ 		Inje Univ, Busan Paik Hosp, Dept Neurol, Busan, South Korea
Inje Univ, Coll Med, Busan Paik Hosp, Dept Neurol, Busan, South Korea ⓘ 		T-5925-2017
Kim, Sang-Gyu ⓘ
ⓘ 		[JCR상위 4.1] Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE-TPA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study
[JCR상위 7.5] Cilostazol Versus Aspirin in Ischemic Stroke Patients With High-Risk Cerebral Hemorrhage Subgroup Analysis of the PICASSO Trial
[JCR상위 10.3] Changes in High Density Lipoprotein Cholesterol and Risks of Cardiovascular Events: A Post Hoc Analysis from the PICASSO Trial ⓘ 		SCIE ⓘ 4.1 CLINICAL NEUROLOGY;NEUROSCIENCES
CLINICAL NEUROLOGY;PERIPHERAL VASCULAR DISEASE ⓘ 		jongskim@amc.seoul.kr;
sukwon@amc.seoul.kr; ⓘ
Kim, Jong S.
(Kim, JS) ⓘ 		제1저자 교신저자 Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul 05505, South Korea
Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 4.1] Safety and Efficacy of Otaplimastat in Patients with Acute Ischemic Stroke Requiring tPA (SAFE-TPA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study
[JCR상위 10.3] Management of Acute Stroke Patients Amid the Coronavirus Disease 2019 Pandemic: Scientific Statement of the Korean Stroke Society ⓘ 		SCIE ⓘ 4.1 CLINICAL NEUROLOGY;NEUROSCIENCES
CLINICAL NEUROLOGY;PERIPHERAL VASCULAR DISEASE ⓘ 		jongskim@amc.seoul.kr;
braindoc@snu.ac.kr; ⓘ
페이지 이동: